As of May 25, 2025, Edwards Lifesciences Corp (EW) reports a EV/EBITDA of 26.01.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Edwards Lifesciences Corp's EV/EBITDA to Peers
To better understand Edwards Lifesciences Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Edwards Lifesciences Corp (EW) | 26.01 |
| Penumbra Inc (PEN) | 170.72 |
| ABIOMED Inc (ABMD) | 89.47 |
| Intuitive Surgical Inc (ISRG) | 78.69 |
| Shockwave Medical Inc (SWAV) | 67.85 |
| Insulet Corp (PODD) | 60.29 |
Compared to its competitors, Edwards Lifesciences Corp's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.